Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CME GROUP INC. Director's Dealing 2022

Mar 17, 2022

29871_dirs_2022-03-17_51be7c76-cf47-4323-85c8-c15aa0cc8d88.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CME GROUP INC. (CME)
CIK: 0001156375
Period of Report: 2022-03-15

Reporting Person: Winkler Julie (Sr MD Chief Commercial Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2022-03-15 Common Stock Class A A 2243 $232 Acquired 29599 Direct
2022-03-15 Common Stock Class A F 749 $232 Disposed 28850 Direct

Footnotes

F1: Represents shares earned from a 2018 performance share award based on the company's achievement of total shareholder return relative to the S&P 500 measured over 2019-2021.

F2: Ms. Winkler surrendered shares to the Company in order to fulfill tax withholding obligations in connection with the receipt of the performance share award.